As the leading cause of cancer death in the United States for both men and women, lung cancer is one of the most prevalent cancers in the world. Your lungs are vital organs that bring oxygen into the body when breathing, and push carbon dioxide out when exhaling. As the lungs become damaged, most often due to smoking, they become more susceptible to diseases such as cancer. View our Lung Cancer Providers
Lung cancer screening with low dose CT scans has been shown to detect lung cancers when they are more likely to be cured. If you are a current or past smoker, discuss with your primary care physician or a pulmonologist whether you might be a candidate for this potentially life-saving screening test.
CareMount Medical offers the latest lung cancer diagnostic tools to its patients. A cancer specialist, typically a pulmonologist or thoracic surgeon may order tests such as X-rays, a CT scan, and/or a PET scan prior to recommending a biopsy. For a definitive diagnosis, a biopsy is required. A biopsy is a procedure in which a sample of tissue is removed and examined under a microscope. Cutting edge diagnostic procedures, such as navigational bronchoscopy and EBUS (endoscopic bronchial ultrasound), are used by CareMount’s pulmonologists and thoracic surgeons to help obtain biopsies with the utmost precision. Navigational bronchoscopy is a GPS like system that guides the instrument through the branching airways of the lung to the site of the abnormality with extreme accuracy. EBUS is a bronchoscopy with ultrasound capability to help localize the lung abnormality as well as the regional lymph nodes to help more accurately guide the biopsy needle to the correct location.
There are different types of lung cancers. In general, they are divided into two main categories. Small cell lung cancer is a category by itself and then most other cases of this cancer are grouped into the non-small cell lung cancer category. The treatment approaches to these two categories can be different depending on the specific situation.
Treatment of lung cancer in any one individual is tailored precisely depending on patient characteristics, the size and location of the cancer and in some situations on very specific mutations that we test for in the cancer cells themselves. Standard treatment recommendations may include the following: